|
The need Ensuring we get our five-a-day of fruit and vegetables has become a familiar mantra in the quest for better health.
Research has shown that polyphenols found in fruit and vegetables can offer some protection against diseases such as cancer and heart disease. Cancer and coronary heart disease are two of the UK’s most serious health conditions, together accounting for between 40-50% of adult deaths. However, intensive production methods have reduced the amount of polyphenols found in today’s food supply. This means we have to eat far more fruit and vegetables to reap the benefits.
Now, a British food research company has found ways to extract beneficial ingredients from ancient apples and put them back into our food, making products that could treat some of the UK’s most serious diseases.
The results Orchards in rural Herefordshire have been yielding rare varieties of apple since the sixteenth century. While many of them have now been bred out of the food system, British scientists have discovered they contain concentrated amounts of a polyphenol called epicatechin, which has properties that can increase blood flow by relaxing the arteries. Increased blood flow reduces blood pressure, and helps increase brain blood flow a potentially important factor is the development of vascular dementia.
Coressence’s research to date supports the hypothesis that people who habitually consume epicatechin-rich apple juice exhibit a higher life expectancy relative to other populations.
With the help of investment from the Technology Strategy Board, British company Coressence has been working in partnership with the Institute of Food Research. They have been extracting the epicatechin-rich ingredients from several apple varieties and adding them to existing food products like juice and cereal bars.
One product, marketed under the Evesse brand name, is already on the market in a juice called RDA. The company says a glass of Evesse juice provides the epicatechin equivalent of eating up to 30 modern dessert apples and has the effect of making arteries appear years younger than their actual age. Studies have also shown that the product works to reduce arterial stiffness within 30 minutes, peaks in two hours and lasts for around six hours.
Epicatechin extracted from the Evesse apples has been developed as a liquid and powder supplement and a natural food colour to make other ‘super’ food products that could bring about revolutionary health benefi ts.
As a result of their initial clinical effectiveness Coressence has signed a licensing and supply agreement with Danisco A/S, a world leader in food ingredients, enzymes and bio-based solutions and Evesse EPC is being launched as a daily food supplement in Spring 2011. The company is in the process of signing further global multi-national licences to market their products. According to Mintel, the UK functional foods market was worth £613m in 2007, and is forecast to increase to more than £1bn by 2012.
Three further clinical trials are also underway with results to be published in mid-2011, but the indications are that the ingredients could have cardiovascular, anti-infl ammatory, anticancer and cognitive health benefits.
|
|
Project #J90009J
Project DurationOctober 2006 - September 2008
Partners Coressence Ltd Institute of Food Research
Total project Cost £246,392
Technology Strategy Board investment £123,713
|
 Innovation Results : A British apple a day keeps the doctor away
Printable version (pdf)View/Download
‘Funding from the Technology Strategy Board has helped us take a giant leap forwards in realising the potential health benefits of these ingredients,’
RICHARD WOOD, CHIEF EXECUTIVE, CORESSENCE LTD.
|

|